Tobias Janowitz

Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer

Christine Feig, James O. Jones, Matthew Kraman et al. · Proceedings of the National Academy of Sciences · 2013 · 2K citations

Medicine, Immunology, Oncology +17

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial

Hugo Ford, Andrea Marshall, John Bridgewater et al. · The Lancet Oncology · 2013 · 604 citations · Full text

Public Health, Community Health, Communities Of Practice +14

Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity

Thomas R. Flint, Tobias Janowitz, Claire M. Connell et al. · Cell Metabolism · 2016 · 363 citations · Full text

Life Sciences, Immunology, Oncology +17

CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response

Daniele Biasci, Martin Smoragiewicz, Claire M. Connell et al. · Proceedings of the National Academy of Sciences · 2020 · 258 citations · Full text

Life Sciences, Immunology, Oncology +17

Stromal-driven and Amyloid β-dependent induction of neutrophil extracellular traps modulates tumor growth

Hafsa Munir, James O. Jones, Tobias Janowitz et al. · Nature Communications · 2021 · 169 citations · Full text

Medicine, Cell Biology, Oncology +17